Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Long-Term Debt Repayments (2021 - 2024)

Serina Therapeutics' Long-Term Debt Repayments history spans 3 years, with the latest figure at $1000.0 for Q4 2024.

  • For Q4 2024, Long-Term Debt Repayments fell 92.31% year-over-year to $1000.0; the TTM value through Sep 2025 reached $1000.0, down 97.87%, while the annual FY2024 figure was $35000.0, 27.08% down from the prior year.
  • Long-Term Debt Repayments for Q4 2024 was $1000.0 at Serina Therapeutics, down from $8000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $250000.0 in Q1 2021 and bottomed at $1000.0 in Q4 2024.
  • The 3-year median for Long-Term Debt Repayments is $12000.0 (2023), against an average of $37000.0.
  • The largest YoY upside for Long-Term Debt Repayments was 18.18% in 2024 against a maximum downside of 92.31% in 2024.
  • A 3-year view of Long-Term Debt Repayments shows it stood at $250000.0 in 2021, then tumbled by 94.8% to $13000.0 in 2023, then crashed by 92.31% to $1000.0 in 2024.
  • Per Business Quant, the three most recent readings for SER's Long-Term Debt Repayments are $1000.0 (Q4 2024), $8000.0 (Q3 2024), and $13000.0 (Q2 2024).